Login / Signup

Sodium and Potassium Changes During Decongestion with Acetazolamide - a prespecified analysis from the ADVOR trial.

Sebastiaan DhontPieter MartensEvelyne MeekersJeroen DauwFrederik H VerbruggePetra NijstJozine M Ter MaatenKevin DammanAlexandre MebazaaGerasimos FilippatosFrank RuschitzkaW H Wilson TangMatthias DupontWilfried Mullens
Published in: European journal of heart failure (2023)
Acetazolamide on top of standardized loop diuretic therapy does not lead to clinically important hypokalaemia or hyponatremia and improves decongestion over the entire range of baseline serum potassium and sodium levels. This article is protected by copyright. All rights reserved.
Keyphrases
  • clinical trial
  • acute heart failure
  • phase iii
  • study protocol
  • phase ii
  • transcription factor
  • randomized controlled trial
  • stem cells
  • heart failure
  • bone marrow
  • data analysis